{'52WeekChange': -0.22068965,
 'SandP52WeekChange': None,
 'address1': '13 Gad Feinstein Street',
 'address2': 'Park Rehovot PO Box 2100',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 1.24,
 'askSize': 2900,
 'averageDailyVolume10Day': 134437,
 'averageVolume': 119890,
 'averageVolume10days': 134437,
 'beta': 0.353733,
 'beta3Year': None,
 'bid': 1.07,
 'bidSize': 1000,
 'bookValue': 1.708,
 'category': None,
 'circulatingSupply': None,
 'city': 'Rehovot',
 'companyOfficers': [],
 'country': 'Israel',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 1.12,
 'dayLow': 1.09,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -0.056,
 'enterpriseToRevenue': 2.484,
 'enterpriseValue': 1192183,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '972 8 946 6724',
 'fiftyDayAverage': 1.0674286,
 'fiftyTwoWeekHigh': 1.83,
 'fiftyTwoWeekLow': 0.75,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 22706276,
 'forwardEps': 0.45,
 'forwardPE': 2.4222224,
 'fromCurrency': None,
 'fullTimeEmployees': 143,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.12329,
 'heldPercentInstitutions': 0.28375,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1384819200,
 'lastSplitFactor': '1:2',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/evogene.com',
 'longBusinessSummary': 'Evogene Ltd., a biotechnology company, engages in '
                        'developing various products for life science markets '
                        'through the use of computational predictive biology '
                        'platform in the United States, Israel, Germany, '
                        'Brazil, and internationally. The company operates '
                        'through three segments: Agriculture, Human Health, '
                        'and Industrial Applications. The Agriculture segment '
                        'develops seed traits, ag-chemical products, and '
                        'ag-biological products to enhance plant performance. '
                        'Its products focus on various crops, such as corn, '
                        'soybean, wheat, rice, and cotton. The Industrial '
                        'Application segment develops enhanced castor bean '
                        'seeds to serve as a feedstock source for industrial '
                        'uses. The Human Health segment discovers and develops '
                        'human microbiome-based therapeutics for the treatment '
                        'of immuno-oncology, GI related disorders, and multi '
                        'drug resistant organisms. The company also provides '
                        'medical cannabis products. The company has strategic '
                        'collaborations and licensing agreements with '
                        'agricultural companies, such as BASF, Corteva, Bayer, '
                        'and ChemChina. Evogene Ltd. was founded in 1999 and '
                        'is headquartered in Rehovot, Israel.',
 'longName': 'Evogene Ltd.',
 'market': 'us_market',
 'marketCap': 27487512,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_3274115',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -20631000,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.12,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '972 8 931 1900',
 'previousClose': 1.13,
 'priceHint': 4,
 'priceToBook': 0.63817334,
 'priceToSalesTrailing12Months': 57.26565,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 1.12,
 'regularMarketDayLow': 1.09,
 'regularMarketOpen': 1.12,
 'regularMarketPreviousClose': 1.13,
 'regularMarketPrice': 1.12,
 'regularMarketVolume': 24725,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 25754300,
 'sharesPercentSharesOut': 0.0014,
 'sharesShort': 35340,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 57593,
 'shortName': 'Evogene Ltd.',
 'shortPercentOfFloat': 0.0017,
 'shortRatio': 0.16,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'EVGN',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.801,
 'twoHundredDayAverage': 1.2022302,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'bcca19aa-2c18-3b4d-b705-c438ae6f7284',
 'volume': 24725,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.evogene.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '7612002'}